Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

VTAK
Catheter Precision, Inc.
stock NYSEAMERICAN

At Close
Aug 11, 2026 3:11:50 PM EDT
0.2900USD-4.463%(-0.0140)35,468,297
0.00Bid   0.00Ask   0.0000Spread
Pre-market
Aug 12, 2026 8:31:30 AM EDT
0.2824USD-3.618%(-0.0106)18,467
After-hours
Aug 11, 2026 4:59:30 PM EDT
0.2812USD-4.125%(-0.0121)29,863
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
open chart   
open chart   
Market Cap
1.05M
Headquarters
Carlsbad, California, USA
Industry
Surgical and Medical Instrument Manufacturing
Last Split
Aug 15, 20251for19reverse
VTAK Stats
Avg. Vol. 10 Day
7,885,595
Avg. Vol. 30 Day
14,906,466
Market Cap
1,050,356
Shares Out.
3,609,471
On/Off Exchange
44%/56%
6 Month Beta
-0.73
1 Year Beta
0.79
2 Year Beta
0.35
3 Year Beta
0.55
52 Week Low
0.23
52 Week High
4.31
SMA50
0.72
SMA200
1.41
1 Week
+5.44%
1 Month
-55.26%
3 Month
-67.29%
6 Month
-77.09%
1 Year
-91.15%
2 Year
-98.94%
Profile
advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients' quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of

VTAK Stock Summary

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) stock price today is $0.2900, and today's volume is 35,468,297. VTAK is down -4.463% today. The 30 day average volume is 14,906,466. VTAK market cap is 1.05M with 3,609,471 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC